Chandra Bhagat Pharma Limited

₹55.50As of Sun 8 Nov 2026, 12:00 UTC
BSE:542934Healthcare
Country India
PE (Fwd) •••
TSR 7Y CAGR 4.03%
Div yield —
ROE 9.66%
Drugs, Drug Proprietaries, and Druggists' Sundries
Beta (5Y) 0.32
PE TTM 13.75
TSR TTM 34.97%
Mkt cap ₹418.8M
ROIC 5.92%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹55
(0.41%)
(66.84%)
Hold 8|7|10|6|2
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.50
0.50
0.49
0.51
4.61%
10.32%
4.38%
12.84%
Revenue₹M
26.84
26.28
27.10
28.38
9.54%
1.82%
7.12%
8.59%
Peers (US$4.459M)
Cap (US$)
PE
5.870M
26.87x
2.724M
4.183x
4.390M
—
Capital
TTM
5Y
10Y
Leveragex
0.568
0.046
0.041
EBIT/Intx
1.090
0.478
0.474
Own earn%
54.03
(88.14)
(74.17)
Sh yield%
20.67
23.46
24.36
Owners
Insiders/Inst%
11.43
50.71
Short interest%
5.10
SBC / revenue%
2.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
17–25
$1 testx
—
Incr. ROIC%
3